Ignite Creation Date:
2025-12-25 @ 5:12 AM
Ignite Modification Date:
2026-02-06 @ 3:52 AM
Study NCT ID:
NCT05110027
Status:
COMPLETED
Last Update Posted:
2022-04-04
First Post:
2021-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enpatoran Human Mass Balance and Absolute Bioavailability Study
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-24
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-27
First Submit QC Date:
None
Study First Post Date:
2021-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-22
Last Update Post Date:
2022-04-04
Last Update Post Date Type:
ACTUAL